Place of care manufacturing of chimeric antigen receptor cells: Opportunities and challenges.
Sign Up to like & getrecommendations! Published in 2023 at "Seminars in hematology"
DOI: 10.1053/j.seminhematol.2023.01.001
Abstract: The landscape of therapeutic options for B cell malignancies has fundamentally changed with regulatory and marketing approval of chimeric antigen receptor (CAR)-engineered T cell products. The cell types used for CAR-T production, the length of… read more here.
Keywords: place care; care manufacturing; antigen receptor; chimeric antigen ... See more keywords
Institutional and infrastructure challenges for hospitals producing advanced therapies in the UK: the concept of 'point-of-care manufacturing readiness'.
Sign Up to like & getrecommendations! Published in 2022 at "Regenerative medicine"
DOI: 10.2217/rme-2022-0064
Abstract: Aim: To propose the concept of point-of-care manufacturing readiness for analyzing the capacity that a country, a health system or an institution has developed to manufacture therapies in clinical settings (point-of-care manufacture). The focus is… read more here.
Keywords: point care; care manufacturing; manufacturing readiness; advanced therapies ... See more keywords